Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Triple therapy: valuable new era in treating HIV/AIDS

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Triple therapy: valuable new era in treating HIV/AIDS. Pharmacoecon. Outcomes News 293, 10 (2000). https://doi.org/10.1007/BF03275688

    Download citation

    Keywords

    • Cost Effectiveness
    • Lamivudine
    • Zidovudine
    • Triple Therapy
    • Nucleoside Analogue